HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jialu Huang Selected Research
Jialu Huang Research Topics
Disease
7
Inflammation (Inflammations)
05/2024 - 09/2017
5
Ischemic Stroke
09/2023 - 01/2020
4
Stroke (Strokes)
09/2023 - 01/2020
4
Neoplasms (Cancer)
12/2022 - 06/2021
2
Brain Edema (Cerebral Edema)
05/2023 - 02/2023
2
COVID-19
03/2022 - 01/2021
2
Laryngeal Neoplasms (Laryngeal Cancer)
02/2022 - 01/2020
2
Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2021
2
Hypoxia (Hypoxemia)
01/2022 - 01/2020
2
Tuberculosis (Tuberculoses)
05/2006 - 01/2006
1
Myasthenia Gravis
05/2024
1
Cerebral Infarction
09/2023
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2023
1
Ulcerative Colitis
07/2023
1
Colitis
07/2023
1
Infarction (Infarctions)
02/2023
1
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
02/2023
1
Hypopharyngeal Neoplasms
01/2023
1
Chronic Obstructive Pulmonary Disease (COPD)
10/2022
1
Poisoning
10/2022
1
Hallux Valgus
01/2022
1
Hypertension (High Blood Pressure)
01/2022
1
Genetic Predisposition to Disease (Genetic Predisposition)
01/2022
1
Fatigue
01/2022
1
Circulating Neoplastic Cells
01/2022
1
Liver Neoplasms (Liver Cancer)
01/2022
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2021
1
Cognitive Dysfunction
10/2020
1
Blood Vessel Dissection
01/2020
1
Breast Neoplasms (Breast Cancer)
01/2020
1
Squamous Cell Carcinoma of Head and Neck
01/2020
1
Neoplasm Metastasis (Metastasis)
01/2020
1
Carcinoma (Carcinomatosis)
01/2020
1
Hyperplasia
09/2017
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
12/2022 - 01/2006
4
Glucose (Dextrose)
FDA Link
Generic
09/2023 - 10/2021
3
Adenosine A2A Receptor (Adenosine A2A Receptors)
IBA
01/2022 - 10/2020
3
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 01/2006
2
Lipopolysaccharides
IBA
03/2024 - 09/2017
2
Oxygen (Dioxygen)
IBA
02/2023 - 10/2021
2
Antioxidants
IBA
02/2023 - 10/2021
2
Nucleotides
IBA
01/2023 - 01/2022
2
Elements
IBA
01/2022 - 01/2022
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 01/2020
2
Antigens
IBA
06/2021 - 01/2006
1
Immunoglobulin G (IgG)
IBA
05/2024
1
Cytokines
IBA
05/2024
1
Methylprednisolone
FDA Link
Generic
05/2024
1
Immunoglobulin Fc Fragments
IBA
05/2024
1
Immunoglobulins (Immunoglobulin)
IBA
05/2024
1
Phosphopyruvate Hydratase (Enolase)
IBA
09/2023
1
Dextrans (Dextran)
FDA Link
07/2023
1
Mucins
IBA
07/2023
1
Tight Junction Proteins
IBA
07/2023
1
sodium sulfate (sodium bisulfate)
FDA Link
Generic
07/2023
1
Drinking Water
IBA
07/2023
1
protopine
IBA
07/2023
1
Curcumin
IBA
02/2023
1
hydroxide ion
IBA
10/2022
1
Nanovaccines
IBA
03/2022
1
Therapeutic Uses
IBA
02/2022
1
Triglycerides (Triacylglycerol)
IBA
01/2022
1
Long Noncoding RNA
IBA
01/2022
1
Transcription Factors (Transcription Factor)
IBA
01/2022
1
tempol
IBA
10/2021
1
benzeneboronic acid
IBA
10/2021
1
Hydrogen Peroxide (Hydroperoxide)
FDA Link
Generic
10/2021
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2021
1
Cyclodextrins
IBA
10/2021
1
Enzymes
IBA
10/2021
1
Oligosaccharides
IBA
10/2021
1
Esters
IBA
10/2021
1
pinacol
IBA
10/2021
1
Peptides (Polypeptides)
IBA
10/2021
1
Epitopes
IBA
06/2021
1
Leptin
IBA
01/2021
1
Lysine (L-Lysine)
FDA Link
01/2021
1
RNA (Ribonucleic Acid)
IBA
01/2021
1
Tamoxifen
FDA Link
Generic
01/2020
1
lipopolysaccharide-binding protein
IBA
01/2020
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
01/2020
1
Apolipoprotein C-I (Apolipoprotein C1)
IBA
01/2020
1
Formaldehyde (Formol)
FDA Link
01/2020
1
Apolipoproteins
IBA
01/2020
1
Lipids
IBA
01/2020
1
Paraffin
IBA
01/2020
1
Messenger RNA (mRNA)
IBA
09/2017
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
09/2017
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
09/2017
1
DNA Vaccines
IBA
05/2006
Therapy/Procedure
6
Therapeutics
02/2023 - 01/2020
1
Thrombectomy
05/2023
1
Mesenchymal Stem Cell Transplantation
02/2023
1
Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2022
1
Radiotherapy
02/2022
1
Osteotomy
01/2022
1
Resistance Training
01/2022
1
Immunotherapy
06/2021